Nalesso, F.; Bertacco, A.; Bettin, E.; Cacciapuoti, M.; Bogo, M.; Cattarin, L.; Lanari, J.; Furlanetto, A.; Lanubile, A.; Gringeri, E.;
et al. The Rationale for Combining Normothermic Liver Machine Perfusion with Continuous Renal Replacement Therapy to Maintain Physiological Perfusate during Ex Vivo Organ Perfusion. J. Clin. Med. 2024, 13, 5214.
https://doi.org/10.3390/jcm13175214
AMA Style
Nalesso F, Bertacco A, Bettin E, Cacciapuoti M, Bogo M, Cattarin L, Lanari J, Furlanetto A, Lanubile A, Gringeri E,
et al. The Rationale for Combining Normothermic Liver Machine Perfusion with Continuous Renal Replacement Therapy to Maintain Physiological Perfusate during Ex Vivo Organ Perfusion. Journal of Clinical Medicine. 2024; 13(17):5214.
https://doi.org/10.3390/jcm13175214
Chicago/Turabian Style
Nalesso, Federico, Alessandra Bertacco, Elisabetta Bettin, Martina Cacciapuoti, Marco Bogo, Leda Cattarin, Jacopo Lanari, Alessandro Furlanetto, Alessia Lanubile, Enrico Gringeri,
and et al. 2024. "The Rationale for Combining Normothermic Liver Machine Perfusion with Continuous Renal Replacement Therapy to Maintain Physiological Perfusate during Ex Vivo Organ Perfusion" Journal of Clinical Medicine 13, no. 17: 5214.
https://doi.org/10.3390/jcm13175214
APA Style
Nalesso, F., Bertacco, A., Bettin, E., Cacciapuoti, M., Bogo, M., Cattarin, L., Lanari, J., Furlanetto, A., Lanubile, A., Gringeri, E., Calò, L. A., & Cillo, U.
(2024). The Rationale for Combining Normothermic Liver Machine Perfusion with Continuous Renal Replacement Therapy to Maintain Physiological Perfusate during Ex Vivo Organ Perfusion. Journal of Clinical Medicine, 13(17), 5214.
https://doi.org/10.3390/jcm13175214
